SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-084834
Filing Date
2018-03-16
Accepted
2018-03-16 07:55:28
Documents
253
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d466787d20fa.htm 20-F/A 23080
  Complete submission text file 0001193125-18-084834.txt   29420666

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT sny-20171231.xml EX-101.INS 10164120
3 XBRL TAXONOMY EXTENSION SCHEMA sny-20171231.xsd EX-101.SCH 439874
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sny-20171231_cal.xml EX-101.CAL 289165
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sny-20171231_def.xml EX-101.DEF 1146204
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sny-20171231_lab.xml EX-101.LAB 2112537
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sny-20171231_pre.xml EX-101.PRE 1596213
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-31368 | Film No.: 18694213
SIC: 2834 Pharmaceutical Preparations